Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions

L E M Wisse1,2, S Ravikumar3, R Ittyerah3

  • 1Department of Diagnostic Radiology, Lund University, Klinikgatan 13b, Lund, Sweden. lemwisse@gmail.com.

Insights

Medial temporal lobe (MTL) atrophy is widespread with TAR DNA-binding protein 43 (TDP-43) pathology. Tau pathology is associated with thickness in early Braak staging regions, especially without amyloid-β, suggesting a role for Primary Age-Related Tauopathy.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Radiology

Background:

  • The medial temporal lobe (MTL) is crucial for memory and frequently affected by neurodegenerative diseases.
  • Studying polypathology within the MTL is vital for understanding complex neurodegeneration.
  • High-resolution post-mortem MRI offers a unique window into MTL subregional changes.

Purpose of the Study:

  • To investigate the associations between key neurodegenerative pathologies (tau, TDP-43, amyloid-β, α-synuclein) and the thickness of MTL subregions.
  • To determine if specific proteinopathies correlate with atrophy in distinct MTL areas.
  • To explore the role of tau pathology in early-stage neurodegeneration, particularly in the absence of other pathologies.

Main Methods:

  • Utilized high-resolution post-mortem MRI scans of excised MTL specimens from 58 individuals.
  • Quantified thickness of MTL subregions including the entorhinal cortex (ERC), hippocampus, and related areas.
  • Assessed the severity of tau, TDP-43, amyloid-β, and α-synuclein pathologies using a standardized scale (0-3).
  • Employed Spearman's rank correlations, correcting for age, sex, and hemisphere, to analyze associations between pathologies and thickness.

Main Results:

  • Found significant negative correlations between TAR DNA-binding protein 43 (TDP-43) pathology and thickness across all measured MTL subregions.
  • Identified significant associations between tau pathology and the thickness of Brodmann Area 35 (BA35) and stratum radiatum lacunosum moleculare (SRLM).
  • In cases negative for amyloid-β and TDP-43, tau pathology showed strong negative associations with thickness in the ERC, BA35, subiculum, and cornu ammonis (CA)1.

Conclusions:

  • TDP-43 pathology is linked to widespread atrophy in the medial temporal lobe.
  • Tau pathology is associated with atrophy in regions typically affected early in Braak staging.
  • The strong link between tau and thickness in early Braak regions, independent of amyloid-β, highlights the potential role of Primary Age-Related Tauopathy in neurodegeneration.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
991
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
882